Trademark: 88149613
Word
RNA TO GO
Status
Registered
Status Code
700
Status Date
Tuesday, November 26, 2019
Serial Number
88149613
Registration Number
5918021
Registration Date
Tuesday, November 26, 2019
Mark Type
4000
Filing Date
Wednesday, October 10, 2018
Published for Opposition
Tuesday, September 10, 2019

Trademark Owner History
CUREVAC RNA PRINTER GMBH -
CureVac AG - Original Registrant

Classifications
5 Chemical preparations for medical use, namely, for therapeutic and prophylactic treatment of neurological, neuromuscular, neurodegenerative, infectious and cardiovascular diseases, of autoimmune diseases and tumours, of allergies, of metabolic diseases, of heritable genetic diseases, and for therapies replacing proteins or enzymes; pharmaceutical preparations, namely, immunostimulants, in particular for human or veterinary medical purposes; pharmaceutical preparations, namely, vaccines, in particular for human or veterinary medical purposes; pharmaceutical preparations, namely, adjuvant immunostimulants; pharmaceuticals and medicaments containing biological macromolecules, in particular for human or veterinary purposes for the treatment of neurological, neuromuscular, neurodegenerative and cardiovascular diseases, for the treatment of infectious diseases, autoimmune diseases and tumours, for treatment of metabolic diseases and for treatment of heritable genetic diseases and for protein or enzyme replacement therapy; gene therapy products, namely, nucleic acid macromolecules for in vivo expression for human or veterinary medical use; Dietetic substances adapted for medical use, in particular substances for food supplements namely, dietary food supplements
1 Chemical reagents and biomolecules, in particular biological macromolecules in the nature of nucleic acid for industrial or scientific purposes; Reagents for research purposes
44 Medical and veterinary services, in particular for therapeutic and preventative treatment of tumour diseases, infectious diseases, autoimmune disorders and allergies, for treatment of inherited genetic diseases or for protein or enzyme replacement therapy, and for treatment of neurological, neuromuscular, neurodegenerative and cardiovascular diseases, and for treatment of metabolic disorders
42 Scientific and technological services, namely, technical biology consulting and scientific research services, in particular for identifying and characterizing biological macromolecules; pre-clinical and clinical testing of macromolecules
"RNA"

Trademark Events
May 25, 2022
Automatic Update Of Assignment Of Ownership
Nov 26, 2019
Registered-Principal Register
Sep 10, 2019
Official Gazette Publication Confirmation E-Mailed
Sep 10, 2019
Published For Opposition
Aug 21, 2019
Notification Of Notice Of Publication E-Mailed
Aug 7, 2019
Approved For Pub - Principal Register
Aug 7, 2019
Examiner's Amendment Entered
Aug 7, 2019
Notification Of Examiners Amendment E-Mailed
Aug 7, 2019
Examiners Amendment E-Mailed
Aug 7, 2019
Examiners Amendment -Written
Jul 29, 2019
Teas/Email Correspondence Entered
Jul 29, 2019
Correspondence Received In Law Office
Jul 29, 2019
Assigned To Lie
Jul 23, 2019
Teas Response To Office Action Received
Jan 23, 2019
Notification Of Non-Final Action E-Mailed
Jan 23, 2019
Non-Final Action E-Mailed
Jan 23, 2019
Non-Final Action Written
Jan 22, 2019
Assigned To Examiner
Oct 20, 2018
New Application Office Supplied Data Entered In Tram
Oct 13, 2018
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24